Global Enoxaparin API Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Enoxaparin API Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Enoxaparin API by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Enoxaparin API by Country/Region, 2017, 2022 & 2028

2.2 Enoxaparin API Segment by Packaging

2.2.1 Multi Vials

2.2.2 Pre-Filled Syringes

2.2.3 Others

2.3 Enoxaparin API Sales by Packaging

2.3.1 Global Enoxaparin API Sales Market Share by Packaging (2017-2022)

2.3.2 Global Enoxaparin API Revenue and Market Share by Packaging (2017-2022)

2.3.3 Global Enoxaparin API Sale Price by Packaging (2017-2022)

2.4 Enoxaparin API Segment by Application

2.4.1 COVID-19

2.4.2 Pulmonary Embolism

2.4.3 Atrial Fibrillation

2.4.4 Others

2.5 Enoxaparin API Sales by Application

2.5.1 Global Enoxaparin API Sale Market Share by Application (2017-2022)

2.5.2 Global Enoxaparin API Revenue and Market Share by Application (2017-2022)

2.5.3 Global Enoxaparin API Sale Price by Application (2017-2022)

3 Global Enoxaparin API by Company

3.1 Global Enoxaparin API Breakdown Data by Company

3.1.1 Global Enoxaparin API Annual Sales by Company (2020-2022)

3.1.2 Global Enoxaparin API Sales Market Share by Company (2020-2022)

3.2 Global Enoxaparin API Annual Revenue by Company (2020-2022)

3.2.1 Global Enoxaparin API Revenue by Company (2020-2022)

3.2.2 Global Enoxaparin API Revenue Market Share by Company (2020-2022)

3.3 Global Enoxaparin API Sale Price by Company

3.4 Key Manufacturers Enoxaparin API Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Enoxaparin API Product Location Distribution

3.4.2 Players Enoxaparin API Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Enoxaparin API by Geographic Region

4.1 World Historic Enoxaparin API Market Size by Geographic Region (2017-2022)

4.1.1 Global Enoxaparin API Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Enoxaparin API Annual Revenue by Geographic Region

4.2 World Historic Enoxaparin API Market Size by Country/Region (2017-2022)

4.2.1 Global Enoxaparin API Annual Sales by Country/Region (2017-2022)

4.2.2 Global Enoxaparin API Annual Revenue by Country/Region

4.3 Americas Enoxaparin API Sales Growth

4.4 APAC Enoxaparin API Sales Growth

4.5 Europe Enoxaparin API Sales Growth

4.6 Middle East & Africa Enoxaparin API Sales Growth

5 Americas

5.1 Americas Enoxaparin API Sales by Country

5.1.1 Americas Enoxaparin API Sales by Country (2017-2022)

5.1.2 Americas Enoxaparin API Revenue by Country (2017-2022)

5.2 Americas Enoxaparin API Sales by Packaging

5.3 Americas Enoxaparin API Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Enoxaparin API Sales by Region

6.1.1 APAC Enoxaparin API Sales by Region (2017-2022)

6.1.2 APAC Enoxaparin API Revenue by Region (2017-2022)

6.2 APAC Enoxaparin API Sales by Packaging

6.3 APAC Enoxaparin API Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Enoxaparin API by Country

7.1.1 Europe Enoxaparin API Sales by Country (2017-2022)

7.1.2 Europe Enoxaparin API Revenue by Country (2017-2022)

7.2 Europe Enoxaparin API Sales by Packaging

7.3 Europe Enoxaparin API Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Enoxaparin API by Country

8.1.1 Middle East & Africa Enoxaparin API Sales by Country (2017-2022)

8.1.2 Middle East & Africa Enoxaparin API Revenue by Country (2017-2022)

8.2 Middle East & Africa Enoxaparin API Sales by Packaging

8.3 Middle East & Africa Enoxaparin API Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Enoxaparin API

10.3 Manufacturing Process Analysis of Enoxaparin API

10.4 Industry Chain Structure of Enoxaparin API

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Enoxaparin API Distributors

11.3 Enoxaparin API Customer

12 World Forecast Review for Enoxaparin API by Geographic Region

12.1 Global Enoxaparin API Market Size Forecast by Region

12.1.1 Global Enoxaparin API Forecast by Region (2023-2028)

12.1.2 Global Enoxaparin API Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Enoxaparin API Forecast by Packaging

12.7 Global Enoxaparin API Forecast by Application

13 Key Players Analysis

13.1 Pfizer Inc.

13.1.1 Pfizer Inc. Company Information

13.1.2 Pfizer Inc. Enoxaparin API Product Offered

13.1.3 Pfizer Inc. Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Inc. Main Business Overview

13.1.5 Pfizer Inc. Latest Developments

13.2 Sanofi S.A.

13.2.1 Sanofi S.A. Company Information

13.2.2 Sanofi S.A. Enoxaparin API Product Offered

13.2.3 Sanofi S.A. Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi S.A. Main Business Overview

13.2.5 Sanofi S.A. Latest Developments

13.3 GlaxoSmithKline Plc

13.3.1 GlaxoSmithKline Plc Company Information

13.3.2 GlaxoSmithKline Plc Enoxaparin API Product Offered

13.3.3 GlaxoSmithKline Plc Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Plc Main Business Overview

13.3.5 GlaxoSmithKline Plc Latest Developments

13.4 Bristol Myer Squibb Company

13.4.1 Bristol Myer Squibb Company Company Information

13.4.2 Bristol Myer Squibb Company Enoxaparin API Product Offered

13.4.3 Bristol Myer Squibb Company Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bristol Myer Squibb Company Main Business Overview

13.4.5 Bristol Myer Squibb Company Latest Developments

13.5 Bohehringer Ingelheim

13.5.1 Bohehringer Ingelheim Company Information

13.5.2 Bohehringer Ingelheim Enoxaparin API Product Offered

13.5.3 Bohehringer Ingelheim Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bohehringer Ingelheim Main Business Overview

13.5.5 Bohehringer Ingelheim Latest Developments

13.6 Eisai Inc.

13.6.1 Eisai Inc. Company Information

13.6.2 Eisai Inc. Enoxaparin API Product Offered

13.6.3 Eisai Inc. Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eisai Inc. Main Business Overview

13.6.5 Eisai Inc. Latest Developments

13.7 Teva Pharmaceutical Industries Ltd.

13.7.1 Teva Pharmaceutical Industries Ltd. Company Information

13.7.2 Teva Pharmaceutical Industries Ltd. Enoxaparin API Product Offered

13.7.3 Teva Pharmaceutical Industries Ltd. Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

13.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments

13.8 Abbot India Limited, Novartis AG

13.8.1 Abbot India Limited, Novartis AG Company Information

13.8.2 Abbot India Limited, Novartis AG Enoxaparin API Product Offered

13.8.3 Abbot India Limited, Novartis AG Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Abbot India Limited, Novartis AG Main Business Overview

13.8.5 Abbot India Limited, Novartis AG Latest Developments

13.9 ChemWerth

13.9.1 ChemWerth Company Information

13.9.2 ChemWerth Enoxaparin API Product Offered

13.9.3 ChemWerth Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ChemWerth Main Business Overview

13.9.5 ChemWerth Latest Developments

13.10 Laboratorios Farmaceuticos ROVI SA

13.10.1 Laboratorios Farmaceuticos ROVI SA Company Information

13.10.2 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Product Offered

13.10.3 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Laboratorios Farmaceuticos ROVI SA Main Business Overview

13.10.5 Laboratorios Farmaceuticos ROVI SA Latest Developments

13.11 Gland Pharma Limited

13.11.1 Gland Pharma Limited Company Information

13.11.2 Gland Pharma Limited Enoxaparin API Product Offered

13.11.3 Gland Pharma Limited Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Gland Pharma Limited Main Business Overview

13.11.5 Gland Pharma Limited Latest Developments

13.12 Hanways Chempharma Co. Ltd

13.12.1 Hanways Chempharma Co. Ltd Company Information

13.12.2 Hanways Chempharma Co. Ltd Enoxaparin API Product Offered

13.12.3 Hanways Chempharma Co. Ltd Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Hanways Chempharma Co. Ltd Main Business Overview

13.12.5 Hanways Chempharma Co. Ltd Latest Developments

13.13 Changzhou Qianhong Biopharma

13.13.1 Changzhou Qianhong Biopharma Company Information

13.13.2 Changzhou Qianhong Biopharma Enoxaparin API Product Offered

13.13.3 Changzhou Qianhong Biopharma Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Changzhou Qianhong Biopharma Main Business Overview

13.13.5 Changzhou Qianhong Biopharma Latest Developments

13.14 Shenzhen Hepalink Pharmaceutical Group

13.14.1 Shenzhen Hepalink Pharmaceutical Group Company Information

13.14.2 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Product Offered

13.14.3 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Shenzhen Hepalink Pharmaceutical Group Main Business Overview

13.14.5 Shenzhen Hepalink Pharmaceutical Group Latest Developments

14 Research Findings and Conclusion

Table 1. Enoxaparin API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Enoxaparin API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Multi Vials

Table 4. Major Players of Pre-Filled Syringes

Table 5. Major Players of Others

Table 6. Global Enoxaparin API Sales by Packaging (2017-2022) & (K Units)

Table 7. Global Enoxaparin API Sales Market Share by Packaging (2017-2022)

Table 8. Global Enoxaparin API Revenue by Packaging (2017-2022) & ($ million)

Table 9. Global Enoxaparin API Revenue Market Share by Packaging (2017-2022)

Table 10. Global Enoxaparin API Sale Price by Packaging (2017-2022) & (US$/Unit)

Table 11. Global Enoxaparin API Sales by Application (2017-2022) & (K Units)

Table 12. Global Enoxaparin API Sales Market Share by Application (2017-2022)

Table 13. Global Enoxaparin API Revenue by Application (2017-2022)

Table 14. Global Enoxaparin API Revenue Market Share by Application (2017-2022)

Table 15. Global Enoxaparin API Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Enoxaparin API Sales by Company (2020-2022) & (K Units)

Table 17. Global Enoxaparin API Sales Market Share by Company (2020-2022)

Table 18. Global Enoxaparin API Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Enoxaparin API Revenue Market Share by Company (2020-2022)

Table 20. Global Enoxaparin API Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Enoxaparin API Producing Area Distribution and Sales Area

Table 22. Players Enoxaparin API Products Offered

Table 23. Enoxaparin API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Enoxaparin API Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Enoxaparin API Sales Market Share Geographic Region (2017-2022)

Table 28. Global Enoxaparin API Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Enoxaparin API Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Enoxaparin API Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Enoxaparin API Sales Market Share by Country/Region (2017-2022)

Table 32. Global Enoxaparin API Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Enoxaparin API Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Enoxaparin API Sales by Country (2017-2022) & (K Units)

Table 35. Americas Enoxaparin API Sales Market Share by Country (2017-2022)

Table 36. Americas Enoxaparin API Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Enoxaparin API Revenue Market Share by Country (2017-2022)

Table 38. Americas Enoxaparin API Sales by Type (2017-2022) & (K Units)

Table 39. Americas Enoxaparin API Sales Market Share by Packaging (2017-2022)

Table 40. Americas Enoxaparin API Sales by Application (2017-2022) & (K Units)

Table 41. Americas Enoxaparin API Sales Market Share by Application (2017-2022)

Table 42. APAC Enoxaparin API Sales by Region (2017-2022) & (K Units)

Table 43. APAC Enoxaparin API Sales Market Share by Region (2017-2022)

Table 44. APAC Enoxaparin API Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Enoxaparin API Revenue Market Share by Region (2017-2022)

Table 46. APAC Enoxaparin API Sales by Packaging (2017-2022) & (K Units)

Table 47. APAC Enoxaparin API Sales Market Share by Packaging (2017-2022)

Table 48. APAC Enoxaparin API Sales by Application (2017-2022) & (K Units)

Table 49. APAC Enoxaparin API Sales Market Share by Application (2017-2022)

Table 50. Europe Enoxaparin API Sales by Country (2017-2022) & (K Units)

Table 51. Europe Enoxaparin API Sales Market Share by Country (2017-2022)

Table 52. Europe Enoxaparin API Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Enoxaparin API Revenue Market Share by Country (2017-2022)

Table 54. Europe Enoxaparin API Sales by Type (2017-2022) & (K Units)

Table 55. Europe Enoxaparin API Sales Market Share by Packaging (2017-2022)

Table 56. Europe Enoxaparin API Sales by Application (2017-2022) & (K Units)

Table 57. Europe Enoxaparin API Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Enoxaparin API Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Enoxaparin API Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Enoxaparin API Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Enoxaparin API Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Enoxaparin API Sales by Packaging (2017-2022) & (K Units)

Table 63. Middle East & Africa Enoxaparin API Sales Market Share by Packaging (2017-2022)

Table 64. Middle East & Africa Enoxaparin API Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Enoxaparin API Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Enoxaparin API

Table 67. Key Market Challenges & Risks of Enoxaparin API

Table 68. Key Industry Trends of Enoxaparin API

Table 69. Enoxaparin API Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Enoxaparin API Distributors List

Table 72. Enoxaparin API Customer List

Table 73. Global Enoxaparin API Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Enoxaparin API Sales Market Forecast by Region

Table 75. Global Enoxaparin API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Enoxaparin API Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Enoxaparin API Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Enoxaparin API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Enoxaparin API Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Enoxaparin API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Enoxaparin API Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Enoxaparin API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Enoxaparin API Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Enoxaparin API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Enoxaparin API Sales Forecast by Packaging (2023-2028) & (K Units)

Table 86. Global Enoxaparin API Sales Market Share Forecast by Packaging (2023-2028)

Table 87. Global Enoxaparin API Revenue Forecast by Packaging (2023-2028) & ($ Millions)

Table 88. Global Enoxaparin API Revenue Market Share Forecast by Packaging (2023-2028)

Table 89. Global Enoxaparin API Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Enoxaparin API Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Enoxaparin API Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Enoxaparin API Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer Inc. Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Inc. Enoxaparin API Product Offered

Table 95. Pfizer Inc. Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Pfizer Inc. Main Business

Table 97. Pfizer Inc. Latest Developments

Table 98. Sanofi S.A. Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi S.A. Enoxaparin API Product Offered

Table 100. Sanofi S.A. Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Sanofi S.A. Main Business

Table 102. Sanofi S.A. Latest Developments

Table 103. GlaxoSmithKline Plc Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 104. GlaxoSmithKline Plc Enoxaparin API Product Offered

Table 105. GlaxoSmithKline Plc Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. GlaxoSmithKline Plc Main Business

Table 107. GlaxoSmithKline Plc Latest Developments

Table 108. Bristol Myer Squibb Company Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 109. Bristol Myer Squibb Company Enoxaparin API Product Offered

Table 110. Bristol Myer Squibb Company Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Bristol Myer Squibb Company Main Business

Table 112. Bristol Myer Squibb Company Latest Developments

Table 113. Bohehringer Ingelheim Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 114. Bohehringer Ingelheim Enoxaparin API Product Offered

Table 115. Bohehringer Ingelheim Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Bohehringer Ingelheim Main Business

Table 117. Bohehringer Ingelheim Latest Developments

Table 118. Eisai Inc. Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 119. Eisai Inc. Enoxaparin API Product Offered

Table 120. Eisai Inc. Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Eisai Inc. Main Business

Table 122. Eisai Inc. Latest Developments

Table 123. Teva Pharmaceutical Industries Ltd. Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 124. Teva Pharmaceutical Industries Ltd. Enoxaparin API Product Offered

Table 125. Teva Pharmaceutical Industries Ltd. Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Teva Pharmaceutical Industries Ltd. Main Business

Table 127. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 128. Abbot India Limited, Novartis AG Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 129. Abbot India Limited, Novartis AG Enoxaparin API Product Offered

Table 130. Abbot India Limited, Novartis AG Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Abbot India Limited, Novartis AG Main Business

Table 132. Abbot India Limited, Novartis AG Latest Developments

Table 133. ChemWerth Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 134. ChemWerth Enoxaparin API Product Offered

Table 135. ChemWerth Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. ChemWerth Main Business

Table 137. ChemWerth Latest Developments

Table 138. Laboratorios Farmaceuticos ROVI SA Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 139. Laboratorios Farmaceuticos ROVI SA Enoxaparin API Product Offered

Table 140. Laboratorios Farmaceuticos ROVI SA Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Laboratorios Farmaceuticos ROVI SA Main Business

Table 142. Laboratorios Farmaceuticos ROVI SA Latest Developments

Table 143. Gland Pharma Limited Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 144. Gland Pharma Limited Enoxaparin API Product Offered

Table 145. Gland Pharma Limited Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Gland Pharma Limited Main Business

Table 147. Gland Pharma Limited Latest Developments

Table 148. Hanways Chempharma Co. Ltd Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 149. Hanways Chempharma Co. Ltd Enoxaparin API Product Offered

Table 150. Hanways Chempharma Co. Ltd Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Hanways Chempharma Co. Ltd Main Business

Table 152. Hanways Chempharma Co. Ltd Latest Developments

Table 153. Changzhou Qianhong Biopharma Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 154. Changzhou Qianhong Biopharma Enoxaparin API Product Offered

Table 155. Changzhou Qianhong Biopharma Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Changzhou Qianhong Biopharma Main Business

Table 157. Changzhou Qianhong Biopharma Latest Developments

Table 158. Shenzhen Hepalink Pharmaceutical Group Basic Information, Enoxaparin API Manufacturing Base, Sales Area and Its Competitors

Table 159. Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Product Offered

Table 160. Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Shenzhen Hepalink Pharmaceutical Group Main Business

Table 162. Shenzhen Hepalink Pharmaceutical Group Latest Developments

List of Figures

Figure 1. Picture of Enoxaparin API

Figure 2. Enoxaparin API Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Enoxaparin API Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Enoxaparin API Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Enoxaparin API Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Multi Vials

Figure 10. Product Picture of Pre-Filled Syringes

Figure 11. Product Picture of Others

Figure 12. Global Enoxaparin API Sales Market Share by Packaging in 2021

Figure 13. Global Enoxaparin API Revenue Market Share by Packaging (2017-2022)

Figure 14. Enoxaparin API Consumed in COVID-19

Figure 15. Global Enoxaparin API Market: COVID-19 (2017-2022) & (K Units)

Figure 16. Enoxaparin API Consumed in Pulmonary Embolism

Figure 17. Global Enoxaparin API Market: Pulmonary Embolism (2017-2022) & (K Units)

Figure 18. Enoxaparin API Consumed in Atrial Fibrillation

Figure 19. Global Enoxaparin API Market: Atrial Fibrillation (2017-2022) & (K Units)

Figure 20. Enoxaparin API Consumed in Others

Figure 21. Global Enoxaparin API Market: Others (2017-2022) & (K Units)

Figure 22. Global Enoxaparin API Sales Market Share by Application (2017-2022)

Figure 23. Global Enoxaparin API Revenue Market Share by Application in 2021

Figure 24. Enoxaparin API Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Enoxaparin API Revenue Market Share by Company in 2021

Figure 26. Global Enoxaparin API Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Enoxaparin API Revenue Market Share by Geographic Region in 2021

Figure 28. Global Enoxaparin API Sales Market Share by Region (2017-2022)

Figure 29. Global Enoxaparin API Revenue Market Share by Country/Region in 2021

Figure 30. Americas Enoxaparin API Sales 2017-2022 (K Units)

Figure 31. Americas Enoxaparin API Revenue 2017-2022 ($ Millions)

Figure 32. APAC Enoxaparin API Sales 2017-2022 (K Units)

Figure 33. APAC Enoxaparin API Revenue 2017-2022 ($ Millions)

Figure 34. Europe Enoxaparin API Sales 2017-2022 (K Units)

Figure 35. Europe Enoxaparin API Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Enoxaparin API Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Enoxaparin API Revenue 2017-2022 ($ Millions)

Figure 38. Americas Enoxaparin API Sales Market Share by Country in 2021

Figure 39. Americas Enoxaparin API Revenue Market Share by Country in 2021

Figure 40. United States Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Enoxaparin API Sales Market Share by Region in 2021

Figure 45. APAC Enoxaparin API Revenue Market Share by Regions in 2021

Figure 46. China Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Enoxaparin API Sales Market Share by Country in 2021

Figure 53. Europe Enoxaparin API Revenue Market Share by Country in 2021

Figure 54. Germany Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Enoxaparin API Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Enoxaparin API Revenue Market Share by Country in 2021

Figure 61. Egypt Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Enoxaparin API Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Enoxaparin API in 2021

Figure 67. Manufacturing Process Analysis of Enoxaparin API

Figure 68. Industry Chain Structure of Enoxaparin API

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles